CN Patent

CN103467482B — 稠合嘧啶类化合物，其制备方法，中间体，组合物和应用

Assigned to Shanghai Yunyi Health Technology Development Co ltd · Expires 2017-05-10 · 9y expired

What this patent protects

本发明公开了一种如式I所示的稠合嘧啶类化合物、其药学上可接受的盐、水合物、溶剂合物、其光学异构体或其前药，其制备方法、中间体、组合物及其应用。本发明的稠合嘧啶类化合物具有抑制PI3激酶的活性，并可用于治疗因PI3激酶的异常活性引起的疾病，例如癌症等，或者用于制备治疗这些疾病的药物。

USPTO Abstract

本发明公开了一种如式I所示的稠合嘧啶类化合物、其药学上可接受的盐、水合物、溶剂合物、其光学异构体或其前药，其制备方法、中间体、组合物及其应用。本发明的稠合嘧啶类化合物具有抑制PI3激酶的活性，并可用于治疗因PI3激酶的异常活性引起的疾病，例如癌症等，或者用于制备治疗这些疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103467482B
Jurisdiction
CN
Classification
—
Expires
2017-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Yunyi Health Technology Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.